The CEO of CryoPort Inc is Exercising Options


Today it was reported that the CEO of CryoPort Inc (Other OTC: CYRX), Richard J. Berman, exercised options to sell 20,000 CYRX shares at $3.07 a share, for a total transaction value of $256.2K.

See today’s analyst top recommended stocks >>

Based on CryoPort Inc’s latest earnings report for the quarter ending June 30, the company posted quarterly revenue of $4.63 million and GAAP net loss of $2.47 million. In comparison, last year the company earned revenue of $2.92 million and had a GAAP net loss of $1.86 million. Currently, CryoPort Inc has an average volume of 429.8K. The Company has a Price to Book ratio of 14.4689.

Based on 3 analyst ratings, the analyst consensus is Strong Buy with an average price target of $19.00, reflecting a -34.6% downside.

The insider sentiment on CryoPort Inc has been negative according to 14 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

CryoPort, Inc. engages in the provision of logistics solutions to the life science industry. It also provides logistics solutions for biologic materials such as immunotherapies, stem cells, CAR-T cells, and reproductive cells for clients worldwide, including points-of-care, clinical research organizations central laboratories, biopharmaceuticals, contract manufacturing, health centers, and university researchers. It offers personalized medicine, immunotherapies, cellular therapies, CAR T-cell therapies, stem cell therapies, cell lines, vaccines, diagnostic materials, semen, eggs, embryos, cord blood, bio-pharmaceuticals, infectious substances, and other commodities that require continuous exposure to certain ranges of precision-controlled temperatures. The company was founded on May 25, 1990 and is headquartered in Lake Forest, CA.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts